- Therapeutic challenges in acquired factor VIII deficiencyPeter W Collins
Arthur Bloom Haemophilia Centre, School of Medicine, Cardiff University, Cardiff, United Kingdom
Hematology Am Soc Hematol Educ Program 2012:369-74. 2012..Relapse is common (10%-20%) in the first 6 months after immunosuppression is stopped, and patients need to be followed up regularly to allow early diagnosis and treatment of relapse...
- Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Peter Collins
Arthur Bloom Haemophilia Centre, University Hospital of Wales, School of Medicine, Cardiff University, Cardiff, UK
Blood 120:47-55. 2012..Outcome was not affected by the choice of first-line therapy. The likelihood of achieving stable remission was not affected by underlying etiology but was influenced by the presenting inhibitor titer and FVIII level...
- Consensus recommendations for the diagnosis and treatment of acquired hemophilia APeter Collins
Arthur Bloom Hemophilia centre, School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, CF14 4XN, UK
BMC Res Notes 3:161. 2010..AHA usually presents to clinicians without prior experience of the disease, therefore diagnosis is frequently delayed and bleeds under treated...
- Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophiliaP W Collins
School of Medicine, Cardiff University and University Hospital of Wales, Cardiff, UK
Haemophilia 17:2-10. 2011..If PK is to be used in routine clinical practice, a simplified method for its measurement is required and this methodology is becoming available...
- A population based, unselected, consecutive cohort of patients with acquired haemophilia APeter Collins
Department of Haematology, University of Wales College of Medicine, Cardiff, UK
Br J Haematol 124:86-90. 2004....